Patent Assignment
Reel/Frame 016851/0045
License Agreement
Recorded: 2005-10-04
Pages: 4
Assignor
CONTROL DELIVERY SYSTEMS, INC.
Executed: 2003-12-09
Assignee
BAUSCH & LOMB INCORPORATED
ONE BAUSCH & LOMB PLACE, ROCHESTER, NEW YORK, 14604
Covered Properties
(21)
Sustained Release Drug Delivery Devices
Patent:
5,378,475 →
Application:
07/658,695 →
Permeable, Non-Irritating Prodrugs of Nonsteroidal and Steroidal Agents
Patent:
5,681,964 →
Application:
08/318,160 →
Implantable Controlled Release Device to Deliver Drugs Directly to an Internal Portion of the Body
Patent:
5,773,019 →
Application:
08/534,854 →
Sustained Release Drug Delivery Devices
Patent:
5,902,598 →
Application:
08/919,221 →
Implantable Controlled Release Device to Deliver Drugs Directly to an Internal Portion of the Body
Patent:
6,001,386 →
Application:
09/059,448 →
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent:
6,217,895 →
Application:
09/273,548 →
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent:
6,375,972 →
Application:
09/558,207 →
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
Application:
10/096,877 →
Publication:
US 2002/0102307
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
Application:
10/253,825 →
Publication:
US 2003/0021828
Processes for forming a drug delivery device
Application:
10/428,214 →
Publication:
US 2004/0009222
Polymer-based, sustained release drug delivery system
Application:
10/449,855 →
Publication:
US 2004/0022853
Methods for monitoring treatment of disease
Application:
10/688,151 →
Publication:
US 2004/0221855
Injectable sustained release delivery devices
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
Application:
10/762,421 →
Publication:
US 2004/0175410
Sustained release device and method for ocular delivery of adrenergic agents
Application:
10/762,439 →
Publication:
US 2004/0208910
Controlled release of highly soluble agents
Application:
10/763,696 →
Publication:
US 2004/0175426
Statistical prediction of clinical outcomes from assessment of multiple symptoms
Application:
60/419,484 →
Steroid suspensions for intraocular use
Application:
60/435,088 →
Processes of forming a drug delivery device
Application:
60/452,348 →
Prediction of changes to visual acuity from assessment of macular edema
Application:
60/468,964 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 29, 2003
From: ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 014221/0911 →
Assignment of Assignor's Interest
Mar 9, 2004
From: CHEN, JIANBING; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015050/0890 →
Assignment of Assignor's Interest
May 18, 2004
From: ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 014640/0858 →
Assignment of Assignor's Interest
May 24, 2004
From: ASHTON, PAUL; GUO, HONG
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 014651/0354 →
Assignment of Assignor's Interest
Jun 15, 2004
From: ASHTON, PAUL; GUO, HONG
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 014731/0714 →
Assignment of Assignor's Interest
Jul 15, 2004
From: ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 014870/0441 →
Assignment of Assignor's Interest
Aug 18, 2004
From: CHOU, KANG-JYE; GUO, HONG; ASHTON, PAUL; SHIMIZU, ROBERT W.
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015695/0061 →
Assignment of Assignor's Interest
Jun 14, 2005
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 016142/0731 →
Assignment of Assignor's Interest
Jun 14, 2005
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 016142/0734 →
Assignment of Assignor's Interest
Jun 14, 2005
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 016135/0697 →
Security Agreement
Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
Security Agreement
Mar 26, 2008
From: BAUSCH & LOMB INCORPORATED; WP PRISM INC.; B&L CRL INC.; B&L CRL PARTNERS L.P.
To: CREDIT SUISSE
Reel/Frame 020733/0765 →
Merger
Feb 19, 2009
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 022288/0245 →
Change of Name
Jan 30, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 027618/0261 →
Change of Name
Apr 6, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 028008/0214 →
Merger
Apr 6, 2012
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 028007/0782 →
Release of Security Interest
Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
Assignment of Assignor's Interest
Sep 12, 2017
From: CHOU, KANG-JYE; GUO, HONG; ASHTON, PAUL; SHIMIZU, ROBERT
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 043562/0585 →
Security Interest
Apr 5, 2018
From: PSIVIDA CORP.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 045848/0670 →
Release of Security Interest
Feb 13, 2019
From: SWK FUNDING LLC, AS AGENT
To: PSIVIDA CORP.; PSIVIDA US, INC.; ICON BIOSCIENCE, INC.
Reel/Frame 048329/0136 →
Security Interest
Feb 13, 2019
From: EYEPOINT PHARMACEUTICALS, INC.; EYEPOINT PHARMACEUTICALS US, INC.; ICON BIOSCIENCE, INC.
To: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 048329/0045 →
Merger
Apr 2, 2019
From: CONTROL DELIVERY SYSTEMS, INC.; PSIVIDA INC.
To: PSIVIDA INC.
Reel/Frame 048768/0796 →
Change of Name
Apr 2, 2019
From: PSIVIDA US, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 049108/0700 →
Change of Name
Apr 3, 2019
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 048787/0610 →
Change of Name
Oct 22, 2019
From: PSIVIDA US, INC.
To: EYEPOINT PHARMACEUTICALS US, INC.
Reel/Frame 050796/0985 →